The global rheumatic heart disease market is anticipated to grow at a CAGR of 6.0% during the forecast period (2024-2031). Global rheumatic heart disease is segmented based on treatment, type, diagnostics tests, and end-users. Based on the type, the global rheumatic heart disease market is segmented into valve, myocarditis, and pericarditis. Besides, the valve is bifurcated into the aortic valve and mitral valve. The valve segment of the global rheumatic heart disease market is projected to hold the most substantial share over the forecast period. The factor that is driving the growth of segment includes rising FDA approvals, the market players initiatives, among others. For instance, in December 2020, In India, Abbott has announced the launch of its clip-delivery system, a minimally invasive heart valve repair product for mitral regurgitation. The system connects parts of the mitral valve’s leaflets, or flaps, to minimize blood backflow (known as mitral regurgitation, or MR), allowing the heart to pump oxygenated blood more effectively.
Get Free Sample link @ https://www.omrglobal.com/request-sample/rheumatic-heart-disease-market
In March 2021, Keystone Heart, Ltd., a medical device innovator dedicated to redefining the quality in structural heart treatment, had announced the agreement done with InterValve Medical Inc., a Venus Medtech company, focuses on offering pioneering aortic valvuloplasty balloon catheters that dilate stenotic valve leaflets and the surrounding native tissue to increase aortic valve area and systemic blood flow. This agreement between the companies was done to distribute and market their balloon aortic valvuloplasty items in the US. V8 and TAV8 balloon catheters, the company’s trademark devices, are the FDA-cleared aortic valvuloplasty balloon catheters with a unique 8-shaped design that is more in line with the anatomical structure of the aortic valve than conventional long cylindrical aortic valvuloplasty balloons. Both balloon catheters are used for stand-alone valvuloplasty procedures as well as procedures before and after transcatheter self-expanding heart valve repair. However, the continuous improvement by leading market players in global rheumatic heart disease drugs and development in biotechnology has brought new opportunities to the global rheumatic heart disease market.
Full report of Rheumatic Heart Disease Market available @ https://www.omrglobal.com/industry-reports/rheumatic-heart-disease-market
Market Coverage
- Segment Covered-
o By Treatment
o By Type
o By Diagnostics Tests
o By End-User
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Abbott Laboratories, F. Hoffmann-La Roche Ltd, Novartis AG, Pfizer, Cook Group Inc., InterValve Medical Inc., Bristol Myers Squibb Co, among others
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Rheumatic Heart Disease Market Report Segment
By Treatment
- Antibiotics Medication
- Anti-Convulsant Medication
- Anti-Inflammatory Treatment
- Surgical Treatment
By Type
- Valve
o Aortic Valve
o Mitral Valve
- Myocarditis
- Pericarditis
By Diagnostics Test
- Electrocardiogram
- Echocardiogram
- Blood Test
- Imaging
By End-User
- Hospitals and Clinics
- Diagnostic Centers
- Research Centers
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/rheumatic-heart-disease-market
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
